RJA
NUS icon

Raymond James & Associates’s Nu Skin NUS Stock Holding History

Raymond James & Associates’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,675
Closed -$321K – 3891
2023
Q2 		$321K Sell
9,675
-154
-2% -$5.67K ﹤0.01% 3215
2023
Q1 		$386K Buy
9,829
+366
+4% +$15.2K ﹤0.01% 3070
2022
Q4 		$399K Sell
9,463
-5,400
-36% -$208K ﹤0.01% 3040
2022
Q3 		$496K Buy
14,863
+711
+5% +$29.6K ﹤0.01% 2862
2022
Q2 		$613K Buy
14,152
+826
+6% +$37.9K ﹤0.01% 2783
2022
Q1 		$638K Sell
13,326
-34,169
-72% -$1.69M ﹤0.01% 2915
2021
Q4 		$2.41M Sell
47,495
-16,323
-26% -$726K ﹤0.01% 2043
2021
Q3 		$2.58M Buy
63,818
+13,903
+28% +$703K ﹤0.01% 1912
2021
Q2 		$2.83M Buy
49,915
+35,248
+240% +$2.01M ﹤0.01% 1862
2021
Q1 		$776K Buy
14,667
+4,017
+38% +$219K ﹤0.01% 2681
2020
Q4 		$582K Sell
10,650
-270
-2% -$14.2K ﹤0.01% 2708
2020
Q3 		$547K Buy
10,920
+989
+10% +$46.9K ﹤0.01% 2547
2020
Q2 		$380K Buy
+9,931
New +$319K ﹤0.01% 2784
2020
Q1 		– Sell
-11,293
Closed -$463K – 3650
2019
Q4 		$463K Buy
11,293
+1,116
+11% +$45.5K ﹤0.01% 2785
2019
Q3 		$433K Buy
+10,177
New +$427K ﹤0.01% 2751
2018
Q4 		– Sell
-26,025
Closed -$2.15M – 3647
2018
Q3 		$2.15M Buy
26,025
+3,322
+15% +$264K ﹤0.01% 1768
2018
Q2 		$1.77M Buy
22,703
+1,378
+6% +$107K ﹤0.01% 1831
2018
Q1 		$1.57M Buy
21,325
+416
+2% +$29.5K ﹤0.01% 1844
2017
Q4 		$1.43M Buy
20,909
+5,656
+37% +$366K ﹤0.01% 1914
2017
Q3 		$938K Buy
15,253
+11,638
+322% +$714K ﹤0.01% 2130
2017
Q2 		$227K Buy
+3,615
New +$206K ﹤0.01% 2908
2014
Q1 		– Sell
-40,026
Closed -$5.53M – 2115
2013
Q4 		$5.53M Sell
40,026
-6,041
-13% -$711K 0.04% 494
2013
Q3 		$4.41M Buy
46,067
+17,446
+61% +$1.48M 0.04% 525
2013
Q2 		$1.75M Buy
+28,621
New +$1.59M 0.02% 876

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Raymond James & Associates's NUS Position: Q3 2023 in Review

Raymond James & Associates sold out of Nu Skin (NUS) in Q3 2023, closing a stake of 9,675 shares — an estimated $321K sold.

Raymond James & Associates first reported a position in NUS in Q2 2013 and held it in 24 quarters. The position peaked at $5.53M in Q4 2013. 212 funds tracked by Wall St. Rank hold NUS as of Q3 2023.

  • Raymond James & Associates reported no remaining Nu Skin position as of Q3 2023 after selling out during the quarter.
  • Raymond James & Associates sold 9,675 Nu Skin shares in Q3 2023, an estimated $321K.
  • Raymond James & Associates first reported a position in Nu Skin in Q2 2013 and held it in 24 quarters.
  • Raymond James & Associates's Nu Skin position peaked at $5.53M in Q4 2013.
  • 212 funds tracked by Wall St. Rank held Nu Skin as of Q3 2023.

Based on Raymond James & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.